Multicomponent Hemostat For The Treatment Of Non-compressible Hemorrhage And Internal Bleeding
Invention type: Technology
/
Case number: #24141
An injectable nanoparticular formulation and method of use thereof for treating non-compressible hemorrhage or internal bleeding has been developed. The formulation includes two interactive components, one a targeting nanoparticle with a polypeptide sequence that binds to a cell present at a site of injury, and the other a crosslinking nanoparticle with a bioorthogonal click-crosslinking group.
Researchers
Paula Hammond
/
Celestine Jia Huey Hong
/
George Velmahos
/
Bradley D. Olsen
Departments: School of Engineering, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomedical Devices & Systems / Chemicals & Materials: Nanotechnology & Nanomaterials
Impact Areas: Healthy Living
-
hemostatic nanoparticles for the treatment of non-compressible hemorrhage and internal bleeding
United States of America | Published application -
hemostatic nanoparticles for the treatment of non-compressible hemorrhage and internal bleeding
Patent Cooperation Treaty | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.